// App-Quantinova.ai

4868 : Tyrosine kinase-dependent modulation of tumor infiltrating immune cells in melanoma

Researchers

Presenter

  • Joel Babdor

Principal Investigators

  • Aurelie Fricot

  • Michael Dussiot

  • Lucile Hebert

  • Patrice Dubreuil

  • Ivan Cruz Moura

  • Thiago Trovati Maciel

  • Olivier Hermine

Medical Centers

  • Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications. INSERM U - IMAGINE Institut. Paris Descartes University - Sorbonne-Paris-Cite University, Paris, France

  • INSERM CRCM - Centre de Recherche en Cancerologie de Marseille, U INSERM, Institut Paoli-Calmettes, CNRS, Universite Aix Marseille, Paris, France.

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Hepatocyte growth factor receptor

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved